What I think is needed more than anything is something Dr. Joseph Shurman has been advocating and successful at for years in southern California —that is, the building of a sense of community among medical and allied providers in the treatment of pain. – Steven D. Passik, PhD, Pain Medicine 2012
- Moore, S. R., & Shurman, J. (1997). Combined neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation for treatment of chronic back pain: a double-blind, repeated measures comparison. Archives of physical medicine and rehabilitation, 78(1), 55-60.
- Shurman, J., Koob, G. F., & Gutstein, H. B. (2010). Opioids, pain, the brain, and hyperkatifeia: a framework for the rational use of opioids for pain. Pain Medicine, 11(7), 1092-1098.
- Sussman, G., Shurman, J., Creed, M. R., Larsen, L. S., Ferrer-Brechner, T., Noll, D., … & Ramalanjaona, G. (1999). Intravenous ondansetron for the control of opioid-induced nausea and vomiting. Clinical therapeutics, 21(7), 1216-1227
- Shurman, J. R., Shurman, G., Groza, A., Groza, A., & Smith, C. DEA and doctors working together.
- Calkins, A. M., Shurman, J., Jaros, M., Kim, R., & Shang, G. (2014). Peripheral Edema and Weight Gain in Adult Patients With Painful Diabetic Peripheral Neuropathy Receiving Gabapentin Enacarbil or Pregabalin Enrolled in a Randomized, Phase 2 Trial. GEn, 2, 3-0.